Q2 2021 Holdings
Filed 2021-08-16 | 30 holdings | $397.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Atea Pharmaceuticals, Inc.(AVIR) | COM | 04683R106 | $120.6M | 5,615,659 | 30.4% |
| Arcutis Biotherapeutics Inc.(ARQT) | COM | 03969K108 | $108.6M | 3,979,292 | 27.3% |
| Annexon Inc(ANNX) | COM | 03589W102 | $73.0M | 3,241,628 | 18.4% |
| C4 Therapeutics, Inc.(CCCC) | COM STK | 12529R107 | $62.1M | 1,642,209 | 15.6% |
| Crinetics Pharmaceuticals(CRNX) | COM | 22663K107 | $31.7M | 1,679,701 | 8.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $480.6K | 5,831,307 | 0.1% |
| Dynavax Technologies Corp(DVAX) | COM | 268158201 | $116.0K | 11,771,708 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $115.0K | 3,080,237 | 0.0% |
| Pharvaris N.V.(PHVS) | COM | N69605108 | $59.3K | 3,180,601 | 0.0% |
| Mersana Therapeutics Inc. | COM | 59045L106 | $50.2K | 3,695,667 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $34.1K | 1,284,314 | 0.0% |
| Syros Pharmaceuticals Inc. | COM | 87184Q107 | $31.5K | 5,785,036 | 0.0% |
| Solid Biosciences Inc | COM | 83422E105 | $29.0K | 7,929,918 | 0.0% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM | 56854Q200 | $25.7K | 1,431,058 | 0.0% |
| Aptinyx Inc | COM | 03836N103 | $25.2K | 8,891,758 | 0.0% |
| Kymera Therapeutics Inc.(KYMR) | COM | 501575104 | $23.3K | 479,605 | 0.0% |
| Nautilus Biotechnology Inc.(NAUT) | COM | 63909J108 | $20.2K | 2,000,000 | 0.0% |
| Savara Inc(SVRA) | COM | 805111101 | $19.8K | 11,622,598 | 0.0% |
| Aeglea BIO Therapeutics Inc(AGLEUSD) | COM | 00773J103 | $18.8K | 2,700,000 | 0.0% |
| Bluebird BIO, Inc. | COM | 09609G100 | $17.2K | 538,179 | 0.0% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $13.8K | 2,119,540 | 0.0% |
| Bctg Acquisition Corp | COM | 05492W103 | $10.5K | 921,790 | 0.0% |
| Research Alliance Corp II | COM CL A | 760873109 | $10.1K | 1,000,000 | 0.0% |
| Arya Sciences Acqu Corp IV | CL A | G31659108 | $7.5K | 700,000 | 0.0% |
| Bcls Acquisition Corp | COM CL A | G0904B105 | $5.1K | 487,500 | 0.0% |
| Panacea Acquisition Corp II | CL A SHS | G6882C106 | $5.0K | 500,000 | 0.0% |
| Omega Alpha Spac | CL A | G6749V107 | $4.0K | 400,000 | 0.0% |
| Frazier Lifesciences Acqu Co | UNIT 12/09/2025 | G3710A121 | $3.0K | 300,000 | 0.0% |
| Jiya Acquisition Corp | COM CL A | 47760M102 | $3.0K | 300,000 | 0.0% |
| Helix Acquisition Corp | COM CL A | G4444C102 | $2.6K | 250,000 | 0.0% |